PRODUCT QUALITY RESEARCH INSTITUTE

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

CATHERINE VICENTE

Phone

2022305199

Tax Period

2024-07-01 to 2025-06-30

PRODUCT QUALITY RESEARCH INSTITUTE, founded in 1999, is a small nonprofit in the Medical Research sector that reported $109K in total revenue in fiscal year 2024. Revenue fell 67% from the prior year — a significant decline worth monitoring. Expenses of $199K exceeded revenue, resulting in a 82% operating deficit.

Mission

THE PRODUCT QUALITY RESEARCH INSTITUTE (PQRI) IS A NON-PROFIT CONSORTIUM OF ORGANIZATIONS WORKING TOGETHER TO GENERATE AND SHARE TIMELY, RELEVANT, AND IMPACTFUL INFORMATION THAT ADVANCES DRUG PRODUCT QUALITY, MANUFACTURING, AND REGULATION. PQRI PROVIDES A UNIQUE FORUM TO FOCUS CRITICAL THINKING, CONDUCT RESEARCH, EXCHANGE INFORMATION, AND PROPOSE METHODOLOGY OR GUIDANCE TO PHARMACEUTICAL COMPANIES, REGULATORS, AND STANDARD SETTING ORGANIZATIONS.

Program Service Accomplishments

Program 1

Expenses: $98,455 Revenue: $100,242

PQRI SERVES AS A FORUM FOR ACADEMIA, INDUSTRY, AND REGULATORY AGENCIES, TO CREATE BEST PRACTICES AND CONDUCT JOINT RESEARCH IN SUPPORT OF GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL REGULATION...

PQRI SERVES AS A FORUM FOR ACADEMIA, INDUSTRY, AND REGULATORY AGENCIES, TO CREATE BEST PRACTICES AND CONDUCT JOINT RESEARCH IN SUPPORT OF GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL REGULATION, LEVERAGING ITS INTELLECTUAL, SCIENTIFIC AND TECHNICAL RESOURCES TO ADVANCE DRUG DEVELOPMENT AND REGULATION TO BENEFIT PATIENTS.PQRI IS COMPRISED OF THREE TECHNICAL COMMITTEES AND A STEERING COMMITTEE. THE STEERING COMMITTEE GUIDES AND DIRECTS THE SCIENTIFIC ACTIVITIES OF PQRI AND IS MADE UP OF 7 MEMBER ORGANIZATIONS REPRESENTING THE PHARMACEUTICAL INDUSTRY, TRADE ORGANIZATIONS AND REGULATORY AGENCIES. THE THREE TECHNICAL COMMITTEES (DEVELOPMENT, BIOPHARMACEUTICS, AND PRODUCT QUALITY) PROVIDE TECHNICAL AND SCIENTIFIC GUIDANCE, DIRECTION, AND REVIEW FOR THE PQRI WORKING GROUPS. THE TECHNICAL COMMITTEES CONSIST OF SCIENTISTS AND REGULATORY EXPERTS FROM MEMBER ORGANIZATIONS AND MAKE TECHNICAL/SCIENTIFIC RECOMMENDATIONS TO THE STEERING COMMITTEE. THE PQRI WORKING GROUPS PERFORM RESEARCH MAINLY THROUGH DATA MINING, LABORATORY EXPERIMENTATION, AND INDUSTRY SURVEYS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,000

Program Service Revenue $100,242

Investment Income $7,721

Other Revenue $491

TOTAL REVENUE $109,454

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $98,455

Other Expenses $199,049

TOTAL EXPENSES $199,049

Year-over-Year Comparison

	2024	2023	Change
Revenue	$109,454	$334,507	-0.7%
Expenses	$199,049	$301,772	-0.3%
Net Income	$-89,595	$32,735	-3.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

125

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DIANE PASKIET	CHAIR	0.75	Officer Director	$0	$0	$0
CATHERINE VICENTE	TREASURER	0.75	Officer Director	$0	$0	$0
DOUG KIEHL	DIRECTOR	0.50	Director	$0	$0	$0
RICHARD HUTCHINSON	DIRECTOR	0.50	Director	$0	$0	$0
DAVID SCHONEKER	DIRECTOR	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$109,454	$199,049	$393,970	$-89,595
2024	No data	No data	No data	No data
2023	$325,431	$275,742	$386,533	$49,689
2022	$208,987	$254,415	$299,261	$-45,428
2021	$151,036	$230,376	$412,181	$-79,340
2020	$99,707	$198,733	$489,900	$-99,026
2019	$308,591	$332,206	$583,541	$-23,615
2018	$223,072	$264,245	$576,976	$-41,173